FORMULATION AND EVALUATION OF NIFEDIPINE SUSTAINED RELEASE PELLETS  

Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2011, Vol 2, Issue 8

Abstract

Nifedipine is a dihydropyridine derivative effectively used in management of various cardio vascular diseases in long-term therapy. The main objective of this work is formulation of Nifedipine sustained release capsules. This drug has low half life of 2 hr and is rapidly eliminated. Nifedipine is practically insoluble in water. Solubility of drug plays a major role in absorption and ultimately affects bioavailability. As it is poorly soluble it shows irregular bioavailability upon oral administration. Nifedipine lacks to maintain its concentration at site of action and side effects are more in conventional dosage form. Hence to minimize these affects we found it as an excellent candidate for sustained released oral drug delivery system. Drug release from marketed tablet modified release formulation showed 98.27% and Nifedipine sustained release pellets in capsules showed 98.80%. After stability studies sustained release capsules showed 99.18%. It is concluded that formulation F9 sustained release pellets in capsule was concluded as superior than marketed sustained release tablet formulation. Among the different formulations prepared, trial no F9 with ethyl cellulose N20 of 0.5% concentration and HPMC E5 with 20% concentration was found to have satisfactory dissolution profile. 

Authors and Affiliations

T Akelesh , Perla Sravan , R Venkatnarayanan

Keywords

Related Articles

MICROENCAPSULATION: ADVANCEMENTS IN APPLICATIONS 

Microcapsule is a tiny sphere including core material/internal phase or fill, coated with/surrounded by wall know as shell, coating or membrane. The usual size range of the microcapsule lies between 1 to 1000 μm. The tec...

CYTOTOXICITY, ANTIMICROBIAL AND NEUROPHARMACOLOGICAL EVALUATION OF ETHANOLIC EXTRACT OF PISTIA STRATIOTES L. 

In phytochemical screening of the ethanolic extract of Pistia stratiotes L. aerial part anthraquinone glycosides, cardiac glycosides, cyanogenetic glycosides, flavonoids, steroids, tannins, carbohydrates were found to be...

DAPAGLIFLOZIN: NEWER MOLECULE FOR TREATMENT OF TYPE 2 DIABETES MELLITUS 

Type 2 diabetes mellitus is a common chronic disease that causes significant morbidity and mortality worldwide. Diabetes results from a combination of increased hepatic glucose production, decreased insulin secretion fro...

PHYTOCHEMICAL INVESTIGATION AND EVALUATION OF ANALGESIC ACTIVITY OF WILLUGHBEIA EDULISROXB AVAILABLE IN BANGLADESH  

Purpose: The present study was an attempt to investigate the phytochemical constituent and to explore the analgesic activity of n- butanol fraction of ethanol extract ofWillughbeia edulis(Family: Apocynaceae). Methods: T...

EVALUATION OF ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY OF SYMPLOCOS RACEMOSA 

In Indian System of Medicine the bark of Symplocos racemosa belonging to family Symplocaceae is used for the treatment of asthma, bronchitis, dropsy, arthritis, inflammation, ulcers, menorrhagia and hepatic ailments. The...

Download PDF file
  • EP ID EP92493
  • DOI -
  • Views 181
  • Downloads 0

How To Cite

T Akelesh, Perla Sravan, R Venkatnarayanan (2011). FORMULATION AND EVALUATION OF NIFEDIPINE SUSTAINED RELEASE PELLETS  . International Research Journal of Pharmacy (IRJP), 2(8), 177-180. https://www.europub.co.uk/articles/-A-92493